Tae Yong Lee
Pharmaceutical Industry
ImmunoMet Therapeutics
Korea
Biography
Mr. Tae Yong Lee joined ImmunoMet’s Board of Directors in March 2017. Mr. Lee is the Founder and Co-Chief Executive Officer at InterVest Co., Ltd. He is the Founder of InterVest Bio Investment Fund and Hansing High Tech Investment Fund II and serves as its Chief Executive Officer. Prior to founding the firm, Mr. Lee founded Prime Plus Capital Co., Ltd. Prior to that, he worked as President of Orion Asset Management in New York. He started his career at Tong Yang Securities as an analyst. Mr. Lee holds an M.S. in Economics at Seoul National University.
Research Interest
=
